Improving HPV vaccine rates among young cancer survivors in pediatric clinics
Implementation of a Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors receiving Follow-Up Care in Pediatric Oncology Practices: A Cluster-Randomized Trial
This study is working to help young cancer survivors, ages 9 to 17, get the HPV vaccine by training their doctors to better talk about it and encourage families to consider it, so more kids can stay healthy after treatment.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10930133 on NIH RePORTER |
What this research studies
This research aims to enhance the uptake of the HPV vaccine among young cancer survivors aged 9 to 17 who are receiving follow-up care in pediatric oncology practices. The study will implement a provider-focused intervention that equips healthcare providers with the knowledge and skills necessary to effectively recommend the HPV vaccine to their patients and their families. By addressing barriers and improving communication, the research seeks to increase vaccination rates, which are currently low among this vulnerable population. The effectiveness of this intervention will be evaluated through a cluster-randomized trial across various pediatric oncology clinics.
Who could benefit from this research
Good fit: Ideal candidates for this research are young cancer survivors aged 9 to 17 who are at least one year off therapy and receiving follow-up care in pediatric oncology clinics.
Not a fit: Patients who are not cancer survivors or those who are currently undergoing cancer treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase HPV vaccination rates among young cancer survivors, thereby reducing their risk of developing HPV-related cancers.
How similar studies have performed: Previous research has shown that provider-focused interventions can effectively increase vaccination rates in similar populations, indicating a promising approach.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Landier, Wendy — University of Alabama at Birmingham
- Study coordinator: Landier, Wendy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.